News Scope Fluidics S.A.

Stocks

SCP

PLSCPFL00018

Biotechnology & Medical Research

Market Closed - Warsaw S.E. Other stock markets 18:55:51 12/06/2026 +03			5-day change	1st Jan Change
124.40 ^PLN	+1.47%		+1.30%	-8.66%

05-27	Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip'	RE
05-15	Scope Fluidics Q1 net loss at 13.5 million zlotys	RE

All News

Mentions Relevance

05-27	Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip'	RE
05-15	Scope Fluidics Q1 net loss at 13.5 million zlotys	RE
05-15	Scope Fluidics S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-21	Scope Fluidics unit Bacteromic starts collaboration with US research center for FDA registration trials	RE
03-25	Scope Fluidics FY net loss at 46.4 million zlotys	RE
03-25	Scope Fluidics S.A. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-09	Scope Fluidics updates objectives for Bacteromic project for 2026-2027	RE
02-20	Scope Fluidics obtains CE-IVDR certification for Bacteromic System	RE
02-11	Scope Fluidics unit adopts plan for production readiness for Bacteromic system panels	RE
01-21	Scope Fluidics unit signs framework distribution deal with SC Elta 90 Medical Research	RE
01-08	Scope Fluidics signs distribution deal for Bacteromic system in Turkey	RE
12-23	Scope Fluidics says unit Bacteromic ends cooperation with MicroLiquid	RE
12-12	Scope Fluidics says unit receives conditional grant approval for Hybolic project	RE
12-02	Scope Fluidics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
12-01	Scope Fluidics Q3 net loss at 11.4 million zlotys	RE
11-03	Scope Fluidics says shareholder sells stake in company	RE
29/10/25	Scope Fluidics says shareholders complete ABB process for 16% of stake	RE
27/10/25	Scope Fluidics starts ABB process	RE
27/10/25	Scope Fluidics to raise share capital via issue of up to 0.4 million new shares	RE
26/09/25	Scope Fluidics extends collaboration for FDA certification	RE
19/09/25	Scope Fluidics S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
19/09/25	Scope Fluidics Q2 net loss at 8.6 mln zlotys	RE
16/09/25	Scope Fluidics approves timeline change for Hybolic project goal	RE
15/09/25	Scope Fluidics board okays EIB financing pursuit for Bacteromic	RE
06/08/25	Scope Fluidics informs about achieving first goal in Edocera project	RE